| |
| |
|
| Insider
Information: |
Toole John J |
| Relationship: |
SVP, Clinical Research |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
19,600 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,330,056 |
|
|
| Total
Shares |
19,600 |
|
|
| Total
Value |
$1,330,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
SVP, Clinical Research |
2007-04-25 |
0 |
2007-04-25 |
19,600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-07-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,696 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-07-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
14,700 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2003-11-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
13,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2003-11-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
200 |
4,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2003-11-28 |
5 |
GA |
$0.00 |
$0 |
I/I |
200 |
9,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-11-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
4,434 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2005-10-25 |
4 |
S |
$47.46 |
$9,492 |
D/D |
(200) |
47,651 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2005-12-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
4,234 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-11-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
4,034 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2003-12-19 |
4 |
OE |
$5.72 |
$8,578 |
D/D |
1,500 |
15,096 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-08-16 |
4 |
S |
$63.68 |
$103,956 |
D/D |
(1,632) |
12,019 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2005-12-23 |
4 |
OE |
$7.08 |
$31,428 |
D/D |
3,800 |
13,551 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-12-20 |
4/A |
OE |
$7.40 |
$29,594 |
D/D |
4,000 |
16,839 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-12-20 |
4 |
OE |
$7.40 |
$29,594 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-12-14 |
4 |
OE |
$2.86 |
$22,169 |
D/D |
7,600 |
9,032 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-08-30 |
4 |
OE |
$6.59 |
$122,220 |
D/D |
8,650 |
23,846 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-11-02 |
4 |
S |
$35.33 |
$332,102 |
I/I |
(9,400) |
4,634 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-08-30 |
4 |
S |
$68.61 |
$686,315 |
D/D |
(10,000) |
13,846 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP |
• – – |
2004-11-10 |
4 |
OE |
$7.08 |
$70,782 |
D/D |
10,000 |
34,692 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,839 |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
16,839 |
20,873 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-04-25 |
4 |
S |
$83.05 |
$1,590,903 |
D/D |
(19,148) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-04-25 |
4 |
OE |
$13.60 |
$260,461 |
D/D |
19,148 |
19,148 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2005-11-22 |
4 |
S |
$53.91 |
$1,079,356 |
D/D |
(20,000) |
9,751 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2005-11-22 |
4 |
OE |
$9.34 |
$186,876 |
D/D |
20,000 |
29,751 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
